Cryolife Inc (NYSE:CRY) Shorted Shares Increased 31.19% After Market Selling

April 24, 2018 - By Vivian Park

CryoLife, Inc. (NYSE:CRY) Logo

Investors sentiment decreased to 1.33 in 2017 Q4. Its down 0.26, from 1.59 in 2017Q3. It dived, as 14 investors sold CryoLife, Inc. shares while 29 reduced holdings. 13 funds opened positions while 44 raised stakes. 24.23 million shares or 2.29% more from 23.69 million shares in 2017Q3 were reported.
Manufacturers Life Co The owns 24,866 shares. Assetmark owns 11 shares. California Employees Retirement Sys invested 0% in CryoLife, Inc. (NYSE:CRY). Meeder Asset Mgmt Inc reported 0% of its portfolio in CryoLife, Inc. (NYSE:CRY). Credit Suisse Ag invested in 0% or 39,351 shares. Oppenheimer Commerce owns 21,848 shares. Aperio Gru Limited Liability holds 0% or 13,057 shares. Teacher Retirement Systems Of Texas holds 0% in CryoLife, Inc. (NYSE:CRY) or 10,268 shares. Parallax Volatility Advisers Lp accumulated 4,872 shares. Moreover, Dimensional Fund L P has 0.02% invested in CryoLife, Inc. (NYSE:CRY). New York State Teachers Retirement has 91,029 shares. Northern Tru holds 1.16M shares. Aqr Management Ltd Liability Corp holds 13,290 shares or 0% of its portfolio. Morgan Stanley, New York-based fund reported 1.81M shares. 26,388 are owned by State Of Tennessee Treasury Department.

Since December 15, 2017, it had 0 insider purchases, and 4 sales for $246,107 activity. McCall Ronald D sold $105,448 worth of CryoLife, Inc. (NYSE:CRY) on Thursday, March 8. 3,333 shares were sold by Davis John E, worth $76,659 on Tuesday, April 17.

The stock of Cryolife Inc (NYSE:CRY) registered an increase of 31.19% in short interest. CRY’s total short interest was 940,100 shares in April as published by FINRA. Its up 31.19% from 716,600 shares, reported previously. With 134,300 shares average volume, it will take short sellers 7 days to cover their CRY’s short positions. The short interest to Cryolife Inc’s float is 3.06%.

The stock decreased 1.50% or $0.35 during the last trading session, reaching $23. About 44,715 shares traded. CryoLife, Inc. (NYSE:CRY) has risen 19.34% since April 24, 2017 and is uptrending. It has outperformed by 7.79% the S&P500.

CryoLife, Inc., together with its subsidiaries, makes and distributes medical devices worldwide. The company has market cap of $842.52 million. It also processes and distributes implantable human tissues for use in cardiac and vascular surgeries. It has a 214.95 P/E ratio. The firm operates in two divisions, Medical Devices and Preservation Services.

CryoLife, Inc. (NYSE:CRY) Ratings Coverage

Among 2 analysts covering Cryolife (NYSE:CRY), 2 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Cryolife had 4 analyst reports since October 31, 2017 according to SRatingsIntel. The firm has “Buy” rating by Canaccord Genuity given on Tuesday, October 31. The rating was maintained by Northland Capital with “Buy” on Monday, November 13. The stock of CryoLife, Inc. (NYSE:CRY) has “Buy” rating given on Tuesday, January 2 by Canaccord Genuity. Canaccord Genuity maintained the shares of CRY in report on Thursday, March 8 with “Buy” rating.

CryoLife, Inc. (NYSE:CRY) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.